Designing Decarbonization: Embedding Sustainability at the Core of Life Sciences Infrastructure

As life sciences companies scale biologics, advanced therapies, and personalized medicines, sustainability has moved from aspiration to operational imperat...

February 27, 2026 | Friday | News
Lupin Expands U.S. CNS Portfolio with FDA Approval of Brivaracetam Oral Solution

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN)   announced that it has received ap...

February 26, 2026 | Thursday | News
Abbott Secures Shareholder Approval for Exact Sciences Acquisition in Major Diagnostics Expansion

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests,  announced th...

February 24, 2026 | Tuesday | News
Rezon Bio Secures U.S. Food and Drug Administration Approval for Commercial Biosimilar Manufacturing at Warsaw-Duchnice Facility

Rezon Bio announces that its Warsaw-Duchnice facility has received approval from the U.S. Food and Drug Administration (FDA) for the commercial manufactu...

February 20, 2026 | Friday | News
Daiichi Sankyo and AstraZeneca Advance ENHERTU Toward EU Approval in Early Breast Cancer Following Landmark Phase 3 Risk Reduction Data

Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-D...

February 20, 2026 | Friday | News
Primera Analytical Solutions Accelerates FDA-Compliant Digital Transformation with Cenevo’s Labguru Platform

Primera Analytical Solutions (Primera), an FDA-compliant analytical Contract Research Organization (CRO), has selected Cenevo’s  Labguru electro...

February 20, 2026 | Friday | News
Telix Advances Precision Neuro-Oncology Strategy with European Filing for TLX101-Px

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has submitted a marketing authorization application (M...

February 19, 2026 | Thursday | News
Bavarian Nordic Secures $22.5 Million Mpox and Smallpox Vaccine Order from Public Health Agency of Canada

Bavarian Nordic A/S  announced a new order valued at USD 22.5 million from the Public Health Agency of Canada (PHAC) for the Company’s mpox an...

February 19, 2026 | Thursday | News
MEDIPOST Inc. Files IND Amendment to Advance Phase III Stem Cell Therapy Trial for Knee Osteoarthritis

MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative disea...

February 16, 2026 | Monday | News
Novocure Advances Pancreatic Cancer Care with FDA Approval of Optune Pax®

Optune Pax concomitant with gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic...

February 13, 2026 | Friday | News
Agilent PD L1 IHC 22C3 PharmDx Secures FDA Approval To Guide KEYTRUDA In Ovarian Cancer

Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab)1, 2 Agilent Technologies Inc. announced ...

February 13, 2026 | Friday | News
Applied Medical Wins $381 Million Antitrust Verdict Against Medtronic

A team from Knobbe Martens obtained a decisive win for medical device manufacturer Applied Medical against Medtronic, Inc. in an antitrust case involving...

February 11, 2026 | Wednesday | News
Eisai’s Leqembi Autoinjector Clears Key Regulatory Step in China for Early Alzheimer’s Treatment

BioArctic AB's (publ) (NASDAQ: BIOA B (Stockholm: BIOA B) partner Eisai announced  that the Biologics License Application (BLA) for the treatme...

February 10, 2026 | Tuesday | News
Geneoscopy Strengthens Diagnostic Market Position After USPTO Invalidates Exact Sciences Patent Claims

Decision removes last patent hurdle as Geneoscopy advances ColoSense®, its RNA-based noninvasive colorectal cancer screening test Geneosco...

February 09, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close